Clinical & Experimental Metastasis

SCI SCIE

国际简称：CLIN EXP METASTAS 参考译名：临床和实验性转移

主要研究方向：医学-肿瘤学非预警期刊审稿周期：约12月

《临床和实验性转移》(Clinical & Experimental Metastasis)是一本由Springer Netherlands出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
57 年发文量
3.7 IF影响因子
未开放 是否OA
92 H-index
1983 创刊年份
Bimonthly 出版周期
English 出版语言

The Journal's scope encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It covers such areas as molecular biology, pharmacology, tumor biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the Journal's core subject of metastasis formation, prevention and treatment.

[ 查看全部 ]

投稿咨询加急咨询

Clinical & Experimental Metastasis期刊信息

ISSN：0262-0898
出版语言：English
是否OA：未开放
E-ISSN：1573-7276
出版地区：NETHERLANDS
是否预警：否
出版商：Springer Netherlands
出版周期：Bimonthly
创刊时间：1983
开源占比：0.3352
Gold OA文章占比：46.75%
OA被引用占比：
出版国人文章占比：0.04
出版撤稿占比：
研究类文章占比：75.44%

Clinical & Experimental Metastasis CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.4

1.187

1.022

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	79 / 428	81%
大类：Medicine 小类：Cancer Research	Q2	70 / 233	70%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Clinical & Experimental Metastasis中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ONCOLOGY 肿瘤学	3区

Clinical & Experimental Metastasis JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	129 / 333	61.4
学科：ONCOLOGY	SCIE	Q2	151 / 333	54.8

Clinical & Experimental Metastasis历年数据统计

影响因子

中科院分区

Clinical & Experimental Metastasis中国学者发文选摘

1、All-site radiotherapy for metastatic ewing's sarcoma: a short-term analysis of feasibility, response, and safet
Author: Yang, YuanYou; Xie, Lu; Sun, Xin; Xu, Jie; Ren, Gang

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s10585-026-10406-0
2、LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axi
Author: Zhang, Yi; Li, Xiaojing; Liu, Shanshan; Xue, Qian; Meng, Peize; Ge, Xiaolu; Zhao, Qingnan; Ma, Haitao

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 2, pp. -. DOI: 10.1007/s10585-026-10399-w
3、A novel multimodal combining radiomics and tumor-stroma ratio (TSR) improves diagnosis of gastric cancer peritoneal metastasi
Author: Zhong, Lin; Lin, Ting; Hou, Dong; Huang, Hongyun; Zhou, Shihai; Lin, Yu; Yu, Yue; Liu, Liangquan; Luo, Jing; Han, Fanghai; Xie, Lang

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 2, pp. -. DOI: 10.1007/s10585-026-10393-2
4、The clinical trial landscape of colorectal cancer liver metastases: profile analysis and target predictio
Author: Li, Ming; Kai, Jinyan; Xu, Yuchentian; Zhu, Shuai; Chen, Zhijun; Zhao, Huiqing; Zhu, Weixiong

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 1, pp. -. DOI: 10.1007/s10585-026-10392-3
5、Predictive significance of anterior and posterior minimal extrathyroidal extension for central lymph node metastasis in cN0 papillary thyroid carcinom
Author: Zhao, Qi; Zhang, Yuyang; Hua, Rui; Lv, Bin; Liu, Nan

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 1, pp. -. DOI: 10.1007/s10585-025-10388-5
6、Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectini
Author: Yang, Xi; Chu, Xiao; Ye, Ruiting; Ni, Jianjiao; Zeng, Ya; Zhou, Yue; Xia, Qing; Wang, Shengping; Li, Qiao; Liu, Shuai; Zhu, Zhengfei; Chu, Li

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 4, pp. -. DOI: 10.1007/s10585-025-10351-4
7、Deep learning MRI-based radiomic models for predicting recurrence in locally advanced nasopharyngeal carcinoma after neoadjuvant chemoradiotherapy: a multi-center stud
Author: Hu, Chunmiao; Xu, Congrui; Chen, Jiaxin; Huang, Yiling; Meng, Qingcheng; Lin, Zhian; Huang, Xinming; Chen, Li

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10349-y
8、Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasi
Author: Yang, Lijun; Li, Jiping

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10340-7